eISSN: 2299-0038
ISSN: 1643-8876
Menopause Review/Przegląd Menopauzalny
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank


Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

without publication fees
2/2019
vol. 18
 
Share:
Send email
Share:
abstract:
Review paper

A comparison of sacral neuromodulation vs. transvaginal electrical stimulation for the treatment of refractory overactive bladder: the impact on quality of life, body image, sexual function, and emotional well-being

Valentina Lucia Lucia La Rosa
1
,
Alessio Platania
2
,
Michał Ciebiera
3
,
Simone Garzon
4
,
Robert Jędra
3
,
Marco Ponta
5
,
Salvatore Butticè
6

  1. Unit of Psychodiagnostics and Clinical Psychology, University of Catania, Catania, Italy
  2. James Street Family Practice, Louth, UK
  3. Second Department of Obstetrics and Gynaecology, The Centre of Postgraduate Medical Education, Warsaw, Poland
  4. Department of Obstetrics and Gynaecology, “Filippo Del Ponte” Hospital, University of Insubria, Varese, Italy
  5. Department of Neurosciences and Reproductive and Odontostomatological Sciences, University of Naples Federico II, Naples, Italy
  6. Department of Urology, San Giovanni di Dio Hospital, Agrigento, Italy
Menopause Rev 2019; 18(2): 89-93
DOI: https://doi.org/10.5114/pm.2019.86834
Online publish date: 2019/06/28
View full text Get citation
 
PlumX metrics:
Overactive bladder syndrome (OAB) is defined by the presence of urinary urgency, with or without urge incontinence, usually accompanied by an increase in urinary frequency and nocturia in the absence of urinary tract infections (UTI) or other diseases. The overall prevalence of OAB symptoms in the female population is reported to be 16.6% and increases with advancing age and menopause. The aetiology of OAB is not fully understood and is likely to affect a heterogeneous population of patients due to changes to their central and peripheral nervous systems. Although OAB is frequently associated with female sexual dysfunction (FSD), its real impact on sexual function in women has been evaluated only in a few studies. The first line of treatment for OAB includes behavioural modification and physical therapy, either as monotherapies or in combination. Many patients who have not had success in managing their symptoms with more conservative therapies may decide to resort to third-line treatments for refractory OAB. These treatments include neuromodulation therapies, particularly transvaginal electrical stimulation (TES) and sacral neuromodulation (SN). The aim of this short commentary is to provide an overview of the effectiveness of these treatments and of their impact on quality of life, body image, sexual function, and emotional well-being.
keywords:

overactive bladder syndrome, transvaginal electrical stimulation, sacral neuromodulation, menopause, quality of life, sexual function
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.